Biomarkers of Kidney Disease, Second Edition, focuses on the basic and clinical research of
biomarkers in common kidney diseases, detailing the characteristics of an ideal biomarker …

Animal models and human studies have been useful in dissecting the molecular
mechanisms of renal disease and finding new disease targets; however, translation of these …

Chronic kidney disease (CKD) is becoming one of the world's most prevalent
noncommunicable chronic diseases. The World Health Organization projects CKD to …

The tools of functional genomics and proteomics have provided us with promising novel
biomarkers for acute kidney injury and chronic kidney disease. It will be important in future …

A number of proteomic and peptidomic analyses of urine from diabetic subjects have been
published in the quest for a biomarker that predicts progression of nephropathy. Less …

Diabetic nephropathy (DN) is the most common cause for end stage renal disease (ESRD).
Next to environmental factors, genetic predispositions determine the susceptibility for DN …

Although diabetic kidney disease (DKD) remains the leading cause of end-stage kidney
disease eventually requiring chronic kidney replacement therapy, the prevalence of DKD …

The prevalence of chronic kidney disease (CKD) is increasing worldwide, and the mortality
rate continues to be unacceptably high. The biomarkers currently used in clinical practice …

Chronic kidney disease (CKD) is an aging-related disorder that represents a major global
public health burden. Current biochemical biomarkers, such as serum creatinine and urinary …

The primary causes of chronic kidney disease (CKD) in children differ from those of CKD in
adults. In the USA the most common diagnostic groups of renal disease that manifest before …